ACPMP Research Foundation Funds Two $50,000 Research Grants
Two grants bring total funding issued by ACPMP to $1,200,000 since 2009
INDEPENDENCE, Ohio - April 22, 2019 - PRLog -- The Appendix Cancer / Pseudomyxoma Peritonei Research Foundation (ACPMP) is pleased to announce the recipients of our 2018 research grant cycle.
With these two grants, ACPMP has now issued $1,200,000 in the form of 25 promising research grants over the past 10 years designed to improve the diagnosis and treatment of Appendix Cancer and Pseudomyxoma Peritonei.
The following researchers will each receive a $50,000, two-year research grant funded by ACPMP and administered by the National Organization of Rare Disorders:
Principal Investigator: Konstantinos Votanopoulos, MD, PhD
Institution: Wake Forest University, USA
Project Title: Immune system enhanced appendiceal cancer organoids for ex vivo determination of immunotherapy efficacy in appendiceal cancer
This grant is issued in memory of Barrett Peterson, Roger Graham, and Aly Kendall
Principal Investigator: Shyh-Dar Li, PhD
Institution: University of British Columbia, Canada
Project Title: Modulation of Tumor Immune Microenvironment for Enhanced Therapy of Pseudomyxoma Peritonei
This grant is issued in memory of Joyce Davitz, Paula Druse, Neil Elkins, Robert FitzGerald, Marcia Fosburg, William Howard, Francine Lane, Doug Lawler, Christina Nuzik, Geoff Pierce, Stanley Pollack, Ronnie Rabon, Laura Rinier, E. Annette Sauer, and Yvonne Stevens
Thank you as always to our dedicated fundraisers and to the many researchers who applied, and to our supporters—you are our inspiration.
The ACPMP Research Foundation is an IRS-designated 501(c)3 charitable organization (EIN: 26-2890160). The Foundation was created in 2008 by a community of individuals affected by Pseudomyxoma Peritonei (PMP), Appendix Cancer, and related Peritoneal Surface Malignancies (PSM). ACPMP is dedicated to (1) funding research to find a cure for Pseudomyxoma Peritonei (PMP), Appendix Cancer, and related Peritoneal Surface Malignancies (PSM), and (2) funding educational programs to educate physicians and patients about these diseases. To learn more, visit https://acpmp.org/